Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FR.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FR.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FU.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FU.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FU.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FU.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FU.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FU.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBL.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBL.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBL.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBL.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBL.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBL.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBL.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBL.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.24.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.24.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.24.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.24.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.24.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.24.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.24.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.24.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.86EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.86EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.86ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.86EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.86EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.86ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.86ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.41.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.41.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.41.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.41.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.41.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.41.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.41.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.41.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used